IL147214A0 - 1-methylcarbapenem derivatives and pharmaceutical compositions containing the same - Google Patents

1-methylcarbapenem derivatives and pharmaceutical compositions containing the same

Info

Publication number
IL147214A0
IL147214A0 IL14721400A IL14721400A IL147214A0 IL 147214 A0 IL147214 A0 IL 147214A0 IL 14721400 A IL14721400 A IL 14721400A IL 14721400 A IL14721400 A IL 14721400A IL 147214 A0 IL147214 A0 IL 147214A0
Authority
IL
Israel
Prior art keywords
same
pharmaceutical compositions
compositions containing
methylcarbapenem derivatives
methylcarbapenem
Prior art date
Application number
IL14721400A
Other languages
English (en)
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of IL147214A0 publication Critical patent/IL147214A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL14721400A 1999-07-06 2000-07-06 1-methylcarbapenem derivatives and pharmaceutical compositions containing the same IL147214A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP19136899 1999-07-06
PCT/JP2000/004496 WO2001002401A1 (fr) 1999-07-06 2000-07-06 Composes de 1-methylcarbapenem cristallin

Publications (1)

Publication Number Publication Date
IL147214A0 true IL147214A0 (en) 2002-08-14

Family

ID=16273433

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14721400A IL147214A0 (en) 1999-07-06 2000-07-06 1-methylcarbapenem derivatives and pharmaceutical compositions containing the same
IL147214A IL147214A (en) 1999-07-06 2001-12-20 1-methylcarbapenem derivatives and pharmaceutical compositions containing the same

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL147214A IL147214A (en) 1999-07-06 2001-12-20 1-methylcarbapenem derivatives and pharmaceutical compositions containing the same

Country Status (21)

Country Link
US (3) US20020128254A1 (ja)
EP (1) EP1193269A4 (ja)
JP (1) JP3476420B2 (ja)
KR (1) KR100750552B1 (ja)
CN (2) CN101077869A (ja)
AU (1) AU758190B2 (ja)
BR (1) BR0012253A (ja)
CA (1) CA2378483C (ja)
CZ (1) CZ20014731A3 (ja)
HK (1) HK1044768A1 (ja)
HU (1) HUP0202255A3 (ja)
IL (2) IL147214A0 (ja)
MX (1) MXPA02000061A (ja)
NO (1) NO327786B1 (ja)
NZ (1) NZ516310A (ja)
PL (1) PL352296A1 (ja)
RU (2) RU2214411C2 (ja)
TR (2) TR200403436T2 (ja)
TW (1) TWI250160B (ja)
WO (1) WO2001002401A1 (ja)
ZA (1) ZA200110413B (ja)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200102908T2 (tr) * 1999-04-06 2002-04-22 Sankyo Company Limited alfa-İkameli karboksilik asit türevleri
US7041660B2 (en) * 1999-07-06 2006-05-09 Sankyo Company, Limited Crystalline 1-methylcarbapenem derivatives
ATE335747T1 (de) * 1999-09-30 2006-09-15 Otsuka Kagaku Kk Kristallines 3-cephem derivat
AU6701101A (en) 2000-06-21 2002-01-02 Cubist Pharm Inc Compositions and methods to improve the oral absorption of antimicrobial agents
KR100451672B1 (ko) * 2001-06-05 2004-10-08 한미약품 주식회사 결정성 세프디니르 산부가염, 이의 제조방법 및 이를이용한 세프디니르의 제조방법
EP1426376A4 (en) * 2001-08-13 2004-12-22 Eisai Co Ltd PROCESS FOR THE PREPARATION OF CARBAPENEM-BASED ANTIBIOTICS
UA78524C2 (en) * 2001-09-26 2007-04-10 Merck & Co Inc A process for preparation of carbapenem compounds
HRP20040264B1 (en) * 2001-09-26 2012-07-31 Merck@Sharp@@@Dohme@Corp Process for making carbapenem compounds
ITMI20012364A1 (it) * 2001-11-09 2003-05-09 Antibioticos Spa Processo di sintesi della cefixima via alchil-o arilsolfonati
CA2644316A1 (en) * 2003-08-25 2005-03-03 Sankyo Company Limited Crystal of 1-methyl carbapenem compound
JP2005097278A (ja) * 2003-08-25 2005-04-14 Sankyo Co Ltd １−メチルカルバペネム化合物の結晶
EP1776365B1 (en) * 2004-06-02 2011-08-03 Sandoz Ag Meropenem intermediate in crystalline form
KR20070112464A (ko) * 2005-03-22 2007-11-26 다이이찌 산쿄 가부시키가이샤 1-알킬피롤리딘 구조를 갖는 카르바페넴 유도체의 제조방법
US8968781B2 (en) 2005-04-29 2015-03-03 Cubist Pharmaceuticals, Inc. Therapeutic compositions
TW200639176A (en) * 2005-05-13 2006-11-16 Sankyo Co Crystal of 1-methyl carbapenem compound
CN101328179B (zh) * 2007-06-15 2011-01-12 山东轩竹医药科技有限公司 含有氧代氮杂环的巯基吡咯烷培南衍生物
CN101412717B (zh) * 2007-10-19 2011-01-12 山东轩竹医药科技有限公司 含有胍基烷酰胺基杂环的碳青霉烯衍生物
US20110054168A1 (en) * 2008-01-17 2011-03-03 Ayumu Kurimoto Method for preparing adenine compound
WO2011143935A1 (zh) * 2010-05-21 2011-11-24 山东轩竹医药科技有限公司 碳青霉烯衍生物或其水合物的晶型及其制备方法与用途
CN103025733B (zh) * 2010-06-03 2015-11-25 山东轩竹医药科技有限公司 碳青霉烯类衍生物或其水合物的晶型及其制备方法与用途
CN108752241B (zh) * 2013-01-15 2021-03-12 默克专利股份公司 用于治疗关节病的酰基胍类

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4260543A (en) 1978-07-03 1981-04-07 Merck & Co., Inc. Crystalline N-formimidoyl thienamycin
US4748238A (en) 1984-03-14 1988-05-31 Merck & Co., Inc. Crystalline 1R,5S,6S,8R-1-methyl-2-(N,N-dimethylcarbamimidoylmethylthio)-6-(1-hydroxyethyl)-1-carbapen-2-em-3-carboxylic acid
US4713451A (en) 1984-04-09 1987-12-15 Merck & Co., Inc. Crystalline dimethyliminothienamycin
IE60588B1 (en) * 1986-07-30 1994-07-27 Sumitomo Pharma Carbapenem compound in crystalline form, and its production and use
US4866171A (en) 1987-04-11 1989-09-12 Lederle (Japan), Ltd. (1R,5S,6S)-2-[(6,7-dihydro-5H-pyrazolo[1,2-a][1,2,4]triazolium-6-yl)]thio-6-[R-1-hydroxyethyl]-1-methyl-carbapenum-3-carboxylate
TW209220B (ja) * 1991-11-27 1993-07-11 Manyu Seiyaku Kk
ATE178066T1 (de) 1992-11-17 1999-04-15 Sankyo Co Krystallines carbapenemderivat
JPH06336483A (ja) * 1993-05-26 1994-12-06 Banyu Pharmaceut Co Ltd アミノアルキルピロリジニルチオカルバペネム誘導体
JPH07291973A (ja) * 1994-04-27 1995-11-07 Banyu Pharmaceut Co Ltd 新規な２−ピロリジニルチオカルバペネム誘導体
JPH09110869A (ja) * 1995-10-23 1997-04-28 Lederle Japan Ltd カルバペネム化合物
CA2241092C (en) * 1995-12-21 2004-04-27 Sankyo Company, Limited 1-methylcarbapenem derivatives
JP2955276B2 (ja) * 1997-06-19 1999-10-04 三共株式会社 １−メチルカルバペネム誘導体を含有する抗菌剤

Also Published As

Publication number Publication date
RU2214411C2 (ru) 2003-10-20
EP1193269A4 (en) 2003-05-28
NO327786B1 (no) 2009-09-21
US20030158174A1 (en) 2003-08-21
JP2001072681A (ja) 2001-03-21
IL147214A (en) 2009-12-24
ZA200110413B (en) 2003-03-19
NZ516310A (en) 2004-05-28
US20020128254A1 (en) 2002-09-12
AU758190B2 (en) 2003-03-20
AU5848700A (en) 2001-01-22
MXPA02000061A (es) 2002-07-02
TWI250160B (en) 2006-03-01
JP3476420B2 (ja) 2003-12-10
RU2003118411A (ru) 2004-12-20
WO2001002401A1 (fr) 2001-01-11
KR20020022761A (ko) 2002-03-27
HUP0202255A3 (en) 2003-10-28
BR0012253A (pt) 2002-03-26
PL352296A1 (en) 2003-08-11
HK1044768A1 (zh) 2002-11-01
KR100750552B1 (ko) 2007-08-20
CN1372560A (zh) 2002-10-02
CN100360530C (zh) 2008-01-09
CN101077869A (zh) 2007-11-28
TR200403436T2 (tr) 2005-03-21
TR200200100T2 (tr) 2002-05-21
CZ20014731A3 (cs) 2002-04-17
US20030232803A1 (en) 2003-12-18
CA2378483A1 (en) 2001-01-11
NO20020030L (no) 2002-03-05
HUP0202255A2 (en) 2002-10-28
NO20020030D0 (no) 2002-01-04
EP1193269A1 (en) 2002-04-03
US6924279B2 (en) 2005-08-02
CA2378483C (en) 2008-09-16

Similar Documents

Publication Publication Date Title
IL138899A0 (en) Amidene derivatives and pharmaceutical compositions containing the same
IL152451A0 (en) 2-chloro-2-nitrophenylcarboxamide derivatives and pharmaceutical compositions containing the same
HUP0301178A3 (en) Glucopyranosyloxybenzylbenzene derivatives and pharmaceutical compositions containing the same
IL144977A0 (en) Pyrrolotriazine derivatives and pharmaceutical compositions containing the same
IL153123A0 (en) N-ureidoheterocycloalkyl-piperidine derivatives and pharmaceutical compositions containing the same
IL140862A (en) Thiobenzimidazole derivatives and pharmaceutical compositions containing the same
IL149757A0 (en) Aminothiazole derivatives and pharmaceutical compositions containing the same
IL202633A0 (en) Sulfonamide derivatives and pharmaceutical compositions containing the same
EG24066A (en) Novel quinuclidine derivatives and medicinal compositions containing the same
IL148517A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
HUP0103406A3 (en) 1h-imidazopyridine derivatives and pharmaceutical compositions thereof
IL150077A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
IL141456A0 (en) Rhodanine derivatives and pharmaceutical compositions containing the same
IL143920A0 (en) 3-heteroarylidenyl-2-indolinone derivatives and pharmaceutical compositions containing the same
IL150224A0 (en) Lipopeptides and pharmaceutical compositions containing the same
IL150223A0 (en) Lipopeptides and pharmaceutical compositions containing the same
HUP0102990A3 (en) Tetrahydroimidazo-naphtyridine derivatives and pharmaceutical compositions thereof
IL158044A0 (en) Cyclopropylindole derivatives and pharmaceutical compositions containing the same
IL156812A0 (en) Phthalazinone-piperidino derivatives and pharmaceutical compositions containing the same
HUP0101381A3 (en) Benzofurylpyrone derivatives and pharmaceutical compositions containing them
IL147214A0 (en) 1-methylcarbapenem derivatives and pharmaceutical compositions containing the same
IL138572A0 (en) Benzoate derivatives and pharmaceutical compositions containing the same
IL149883A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
IL143802A0 (en) Imidazole derivatives and pharmaceutical compositions containing the same
HUP0103203A3 (en) Azaadamantane derivatives and pharmaceutical compositions thereof